Clinical& demographic profiles of patIents with unControllEd asthma in Russia: multi-center oBsErvational ReGistry study

Trial Identifier: D2287R00206
Sponsor: AstraZeneca
Start Date: June 2024
Primary Completion Date: September 2026
Study Completion Date: September 2026
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Astrakhan, Russia
Russia Blagoveshchensk, Russia
Russia Bryansk, Russia
Russia Chelyabinsk, Russia
Russia Gatchina, Russia
Russia Irkutsk, Russia
Russia Ivanovo, Russia
Russia Izhevsk, Russia
Russia Kazan, Russia
Russia Kemerovo, Russia
Russia Krasnodar, Russia
Russia Krasnoyarsk, Russia
Russia Lipetsk, Russia
Russia Makhachkala, Russia
Russia Moscow, Russia
Russia Murmansk, Russia
Russia Nalchik, Russia
Russia Nizhny Novgorod, Russia
Russia Nizhny Tagil, Russia
Russia Novokuznetsk, Russia
Russia Novosibirsk, Russia
Russia Omsk, Russia
Russia Orenburg, Russia
Russia Perm, Russia
Russia Petrozavodsk, Russia
Russia Pyatigorsk, Russia
Russia Rostov-on-Don, Russia
Russia Ryazan, Russia
Russia Saint-Petersburg, Russia
Russia Samara, Russia
Russia Saratov, Russia
Russia Stavropol, Russia
Russia Surgut, Russia
Russia Tomsk, Russia
Russia Tula, Russia
Russia Ufa, Russia
Russia Ulan-Ude, Russia
Russia Verkhnyaya Pyshma, Russia
Russia Vladimir, Russia
Russia Vladivostok, Russia
Russia Voronezh, Russia
Russia Yaroslavl, Russia
Russia Yekaterinburg, Russia
Russia Yuzhno-Sakhalinsk, Russia